Pan-resistant Candida auris isolates from the outbreak in New York are susceptible to ibrexafungerp (a glucan synthase inhibitor)

Int J Antimicrob Agents. 2020 Apr;55(4):105922. doi: 10.1016/j.ijantimicag.2020.105922. Epub 2020 Feb 21.
No abstract available

Publication types

  • Letter